These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. A cross-over study of the cycloplegic effects of a single topical application of cyclopentolate-phenylephrine and routine atropinization for 3.5 days. Zetterström C Acta Ophthalmol (Copenh); 1985 Oct; 63(5):525-9. PubMed ID: 3907259 [TBL] [Abstract][Full Text] [Related]
26. Influence of the time interval between instillation of two drops of cyclopentolate 1% on refraction and dilation of the pupil in children. Stolovitch C; Alster Y; Loewenstein A; Lazar M Am J Ophthalmol; 1995 May; 119(5):637-9. PubMed ID: 7733189 [TBL] [Abstract][Full Text] [Related]
27. Pupillary dilatation with single eyedrop mydriatic combinations. Apt L; Henrick A Am J Ophthalmol; 1980 Apr; 89(4):553-9. PubMed ID: 7369319 [TBL] [Abstract][Full Text] [Related]
28. How safe are ocular drugs in pediatrics? Palmer EA Ophthalmology; 1986 Aug; 93(8):1038-40. PubMed ID: 3763151 [TBL] [Abstract][Full Text] [Related]
29. The mydriaticum cyclopentolate induces severe allergy in a 5-year-old child. Diesner SC; Bannert C; Gruber S; Dehlink E; Eiwegger T; Szepfalusi Z Klin Padiatr; 2014 Jul; 226(4):252-3. PubMed ID: 25010132 [No Abstract] [Full Text] [Related]
30. Refraction of 1-year-old children after cycloplegia with 1% cyclopentolate: comparison with findings after atropinisation. Ingram RM; Barr A Br J Ophthalmol; 1979 May; 63(5):348-52. PubMed ID: 465410 [TBL] [Abstract][Full Text] [Related]
31. Incidence of side effects of topical atropine sulfate and cyclopentolate hydrochloride for cycloplegia in Japanese children: a multicenter study. Wakayama A; Nishina S; Miki A; Utsumi T; Sugasawa J; Hayashi T; Sato M; Kimura A; Fujikado T Jpn J Ophthalmol; 2018 Sep; 62(5):531-536. PubMed ID: 30046935 [TBL] [Abstract][Full Text] [Related]
32. Reliability of diagnostic tests for contact allergy to mydriatic eyedrops. Villarreal O Contact Dermatitis; 1998 Mar; 38(3):150-4. PubMed ID: 9536407 [TBL] [Abstract][Full Text] [Related]
33. Feasibility of ambulatory overnight oximetry in consecutive patients in a dementia clinic. Bliwise DL; Lee JH; Wood-Siverio C; Cellar JS; Lah JJ; Levey AI J Am Geriatr Soc; 2005 Mar; 53(3):545-6. PubMed ID: 15743306 [No Abstract] [Full Text] [Related]
35. [Diagnostic and therapeutic use of cyclopentolate cycloplegia]. Quéré MA Arch Ophtalmol (Paris); 1976 Oct; 36(10):683-8. PubMed ID: 139868 [TBL] [Abstract][Full Text] [Related]
36. Systemic reactions to ophthalmic drug preparations. Fraunfelder FT; Meyer SM Med Toxicol Adverse Drug Exp; 1987; 2(4):287-93. PubMed ID: 3306268 [TBL] [Abstract][Full Text] [Related]
37. Cycloplegic refractions in Japanese children: a comparison of atropine and cyclopentolate. Kawamoto K; Hayasaka S Ophthalmologica; 1997; 211(2):57-60. PubMed ID: 9097304 [TBL] [Abstract][Full Text] [Related]
38. Focal seizures after instillation of cyclomydril to a neonate with congenital CMV infection. Hu L; Dow K J Neonatal Perinatal Med; 2014 Jan; 7(2):147-9. PubMed ID: 25104124 [TBL] [Abstract][Full Text] [Related]
39. Mydriatic efficacy of a cycloplegic spray in the pediatric population. Wesson MD; Bartlett JD; Swiatocha J; Woolley T J Am Optom Assoc; 1993 Sep; 64(9):637-40. PubMed ID: 8227938 [TBL] [Abstract][Full Text] [Related]